DNA hypermethylation of SFRP2 influences the pathology of rheumatoid arthritis through the canonical Wnt signaling in model rats

Abstract In this work, the expression of secreted frizzled related protein 2 (SFRP2) in rheumatoid arthritis (RA) model rats and the mechanisms of SFRP2 on the RA pathogenesis were investigated. Data suggested that SFRP2 was significantly down-regulated in RA model rats compared with normal control, and overexpression of SFRP2 suppressed the RA pathogenesis and the canonical Wnt signaling in fibroblast-like synovial cells (FLS) from RA model rats, whereas knockdown of SFRP2 got an opposite observation. Interestingly, 5-azadC treatment up-regulated the SFRP2 expression, inhibited the FLS proliferation, suppressed the expression of IL-6 and IL-8 and the fibronectin production, suggesting that the decreased SFRP2 in RA model rats was due to the DNA methylation. Furthermore, DNMT1 knockdown up-regulated the SFRP2 expression, DNMT1 overexpression inhibited the SFRP2, and the quantitative methylation-specific PCR (qMSP) confirmed that the DNMT1 has direct methylation roles for the SFRP2 promoter, leading to a regulation of FLS proliferation and fibronectin expression in RA model rats. In addition, up-regulated MeCP2 was involved in the SFRP2 regulation and the pathogenesis of RA model rats, and MeCP2 and DNMT1 have synergistic inhibition roles in the SFRP2 expression. Combination of DNMT1 and DNA methylation may be a promising treatment strategy for individuals with RA in which SFRP2 is down-regulated.

[1]  N. Inestrosa,et al.  Brain glucose metabolism: Role of Wnt signaling in the metabolic impairment in Alzheimer’s disease , 2017, Neuroscience & Biobehavioral Reviews.

[2]  A. Dharmarajan,et al.  The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain. , 2017, International journal of oncology.

[3]  G. Burmester,et al.  Novel treatment strategies in rheumatoid arthritis , 2017, The Lancet.

[4]  G. Schett,et al.  Pathogenetic insights from the treatment of rheumatoid arthritis , 2017, The Lancet.

[5]  M. Guma,et al.  Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis , 2017, Arthritis Research & Therapy.

[6]  R. Guillevin,et al.  Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma , 2017, Front. Physiol..

[7]  Mark Agostino,et al.  Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domains , 2017, The Journal of Biological Chemistry.

[8]  M. Szyf,et al.  DNA methylation and transcription onset in the brain. , 2017, Epigenomics.

[9]  A. Alunno,et al.  One year in review 2017: pathogenesis of rheumatoid arthritis. , 2017, Clinical and experimental rheumatology.

[10]  C. Gabay,et al.  Cardiovascular risk in patients with rheumatoid arthritis , 2017, Seminars in Immunopathology.

[11]  I. McInnes,et al.  Future therapeutic targets in rheumatoid arthritis? , 2017, Seminars in Immunopathology.

[12]  V. Bhargava,et al.  Wnt-β Catenin Signaling Pathway: A Major Player in the Injury Induced Fibrosis and Dysfunction of the External Anal Sphincter , 2017, Scientific Reports.

[13]  R. Tjian,et al.  Regulation of DNA demethylation by the XPC DNA repair complex in somatic and pluripotent stem cells , 2017, Genes & development.

[14]  C. Etiévant,et al.  DNA methyltransferase inhibitors in cancer: From pharmacology to translational studies. , 2017, Biochemical pharmacology.

[15]  Nithya Ramakrishnan,et al.  Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures. , 2017, IET systems biology.

[16]  A. Sidebottom,et al.  Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures. , 2017, European journal of rheumatology.

[17]  W. Zhang,et al.  Investigation of the effect of phlomisoside F on complete Freund's adjuvant-induced arthritis. , 2017, Experimental and therapeutic medicine.

[18]  W. O. Castillo,et al.  Role of GSK3β in breast cancer susceptibility. , 2017, Cancer biomarkers : section A of Disease markers.

[19]  J. Bertrand,et al.  Stable activation of fibroblasts in rheumatic arthritis-causes and consequences. , 2016, Rheumatology.

[20]  J. Isaacs,et al.  Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers , 2016, Nature Reviews Rheumatology.

[21]  L. Donehower,et al.  Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential , 2016, BMC Cancer.

[22]  Alessandro Pedretti,et al.  Structural Effects of Some Relevant Missense Mutations on the MECP2‐DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program , 2016, Molecular informatics.

[23]  I. Matsumoto Monocyte/Macrophage and TNFα-induced adipose related protein (TIARP) in rheumatoid arthritis. , 2016, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[24]  Y. Huang,et al.  DNMT1 activates the canonical Wnt signaling in rheumatoid arthritis model rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2. , 2015, International immunopharmacology.

[25]  E. Keystone,et al.  Rituximab for Rheumatoid Arthritis , 2015, Rheumatology and Therapy.

[26]  Yonglong Chen,et al.  Retinoic Acid-Activated Ndrg1a Represses Wnt/β-catenin Signaling to Allow Xenopus Pancreas, Oesophagus, Stomach, and Duodenum Specification , 2013, PloS one.

[27]  Y. Huang,et al.  New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery. , 2013, Cellular signalling.

[28]  Jun Li,et al.  New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2. , 2013, Cellular signalling.

[29]  C. Deal Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and Focal , 2012, Current Rheumatology Reports.

[30]  D. Daoussis,et al.  The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling? , 2011, Seminars in arthritis and rheumatism.